Compare Quest Diagnostics Inc (DGX) vs Manchester United PLC (MANU) Price & Performance

Quest Diagnostics (DGX) trades at $230.81, up 1.68% today, with a bullish earnings trend after beating EPS estimates for three consecutive quarters. The stock shows a mixed technical picture with a bearish overall signal but trades near key support at $228. Revenue growth accelerated to $11.04B in 2025, and the company maintains solid profitability with a 9.19% net income margin. Recent news highlights growth in consumer testing and a partnership with Apple Health, though Medicare reimbursement cuts pose a headwind.

The outlook is cautiously optimistic, supported by strong fundamentals and a consensus price target of $250 offering 8% upside. Key opportunities include demand for advanced diagnostics and AI adoption, while risks center on regulatory pressure and rising debt levels. Analyst sentiment is mixed with a slight hold bias, reflecting balanced growth prospects against near-term challenges.

Manchester United (MANU) trades at $20.32, up 0.35% on the day, with a bearish technical signal from moving averages and neutral oscillators. The company reported a net loss of $33.02 million for 2025, with revenue of $666.51 million, and has a negative net income margin of -6.34%. Recent news highlights a valuation gap, with the market cap of $3.6 billion seen as a discount to Forbes' $7.2 billion franchise estimate.

The outlook is mixed; improved revenue and Champions League qualification offer upside, but persistent losses and high debt pose risks. Analyst sentiment is cautious with a 40% buy, 60% hold consensus. Key catalysts include profitability improvements and franchise value realization, while execution risks and league-wide financial pressures remain concerns.